Evidence map›Paper›PMID 16805788›Full record

ArticleImmunology2006

Enhancement of CD8 T-cell function through modifying surface glycoproteins in young and old mice.

Amir A Sadighi Akha, Scott B Berger, Richard A Miller

Open access · greenAbstract read
In one paragraph

Article in Immunology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Role of Inactive and ActiveFrontiers in microbiology · 2017
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Immunosupportive therapies in aging.Clinical interventions in aging · 2007
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Amir A Sadighi AkhaDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109-2200, USA. asadighi@umich.edu
Scott B Berger
Richard A Miller
Ann Arbor VA Medical Center · USUniversity of Michigan–Ann Arbor · US

Funding

Research Education CoreP30AG024824 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Neil Alexander · 2004 to 2026
$29.2M
Research Training in BiogerontologyT32AG000114 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCOTT PLETCHER · 1985 to 2026
$12.4M
Activation Defects in T Cells of Aged MiceR01AG019619 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MILLER, RICHARD A · 2000 to 2011
$3.5M
TUMOR INDUCED IMMUNOSUPPRESSIONZ01AG000114 · NIA · AGING · PI LONGO, DAN L. · 2000 to 2007
$241k
Intramural NIH HHS Z01 AG000114NIA NIH HHS AG024824NIA NIH HHS AG19619NIA NIH HHS P30 AG024824NIA NIH HHS R01 AG019619NIA NIH HHS T32 AG000114
6 · The paper itself

Abstract

Previous work from our laboratory has shown that modifying cell surface glycosylation with either a Clostridium perfringens-derived sialidase (CP-Siase), or an O-linked glycoprotein endopeptidase (OSGE) can enhance the function of CD4 T cells from both young and old mice at multiple levels. Here we have re-assessed the effect of age on CD8 T-cell function, and examined the outcome of enzymatic treatment with CP-Siase and OSGE on its different aspects. Pre-treatment of CD8 T cells with either CP-Siase or OSGE led to a significant increase in anti-CD3-mediated Ca2+ response in both young and old mice. Pre-treated CD8 T cells from both age groups also displayed a significant increase in activation-induced CD69 and CD25 expression, and produced significantly higher amounts of interleukin-2 and interferon-gamma in comparison to their untreated counterparts. Furthermore, pretreatment with either enzyme enhanced granzyme B expression in CD8 T cells, and increased their cytolytic activity in vitro. These data support the notion that glycosylated surface proteins hinder CD8 T-cell activation and function in both young and old mice, and raise the possibility of significantly improving CD8 T cell function in older individuals through enzymatic alteration of surface glycoproteins.

Indexed as

AgingAnimalsAntigens, CDAntigens, Differentiation, T-LymphocyteCalciumCD28 AntigensCD3 ComplexCD69 AntigensCD8-Positive T-LymphocytesCells, CulturedCytotoxicity, ImmunologicGlycosylationGranzymesInterferon-gammaInterleukin-2Lectins, C-TypeAntigens, CDAntigens, Differentiation, T-LymphocyteCalciumCD28 AntigensCD3 ComplexCD69 AntigensGranzymesGzmb protein, mouseInterferon-gammaInterleukin-2Lectins, C-TypeMembrane GlycoproteinsMetalloendopeptidasesNeuraminidaseO-sialoglycoprotein endopeptidaseReceptors, Interleukin-2Serine Endopeptidases

Identifiers

PMID16805788
PMCPMC1782347
OpenAlexW2056546402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.